CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-25 | Cambrian BioPharma Inc 10% owner | Purchase | +20,100 | $4.86 | $98K | 5,083,386 |
| 2022-01-24 | Peyer James Director | Purchase | +22,707 | $4.69 | $106K | 5,063,286 |
| 2022-01-24 | Cambrian BioPharma Inc 10% owner | Purchase | +22,707 | $4.69 | $106K | 5,063,286 |
| 2022-01-21 | Peyer James Director | Purchase | +24,703 | $4.94 | $122K | 5,040,579 |
| 2022-01-21 | Cambrian BioPharma Inc 10% owner | Purchase | +24,703 | $4.94 | $122K | 5,040,579 |
| 2022-01-20 | Peyer James Director | Purchase | +20,000 | $5.17 | $103K | 5,015,876 |
| 2022-01-20 | Cambrian BioPharma Inc 10% owner | Purchase | +20,000 | $5.17 | $103K | 5,015,876 |
| 2022-01-19 | Peyer James Director | Purchase | +10,244 | $4.97 | $51K | 4,995,876 |
| 2022-01-19 | Cambrian BioPharma Inc 10% owner | Purchase | +10,244 | $4.97 | $51K | 4,995,876 |
| 2022-01-18 | Peyer James Director | Purchase | +10,000 | $5.08 | $51K | 4,985,632 |
| 2022-01-18 | Cambrian BioPharma Inc 10% owner | Purchase | +10,000 | $5.08 | $51K | 4,985,632 |
| 2022-01-14 | Peyer James Director | Purchase | +6,219 | $4.99 | $31K | 4,975,632 |
| 2022-01-14 | Cambrian BioPharma Inc 10% owner | Purchase | +6,219 | $4.99 | $31K | 4,975,632 |
| 2022-01-13 | Peyer James Director | Purchase | +19,953 | $5.13 | $102K | 4,969,413 |
| 2022-01-13 | Cambrian BioPharma Inc 10% owner | Purchase | +19,953 | $5.13 | $102K | 4,969,413 |
| 2022-01-12 | Peyer James Director | Purchase | +9,202 | $5.22 | $48K | 4,949,460 |
| 2022-01-12 | Cambrian BioPharma Inc 10% owner | Purchase | +9,202 | $5.22 | $48K | 4,949,460 |
| 2022-01-11 | Peyer James Director | Purchase | +10,845 | $5.18 | $56K | 4,940,258 |
| 2022-01-11 | Cambrian BioPharma Inc 10% owner | Purchase | +10,845 | $5.18 | $56K | 4,940,258 |
| 2022-01-10 | Peyer James Director | Purchase | +10,000 | $5.28 | $53K | 4,929,413 |
Page 15 of 20 · 385 trades